110
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Altered levels of cytokines in patients with irritable bowel syndrome are not correlated with fatigue

, , &
Pages 285-291 | Published online: 06 Jul 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sahar M El-Haggar, Sahar K Hegazy, Sherief M Abd-Elsalam, Eslam B Elkaeed, Ahmed A Al-Karmalawy & Mostafa M Bahaa. (2022) RETRACTED ARTICLE: A Potential Role of Ethosuximide and Pentoxifylline in Relieving Abdominal Pain in Irritable Bowel Syndrome Patients Treated with Mebeverine: A Randomized, Double-Blind, Placebo-Controlled Trial. Journal of Inflammation Research 15, pages 1159-1172.
Read now

Articles from other publishers (17)

Giovanni Dothel, Maria Raffaella Barbaro, Aldo Di Vito, Gloria Ravegnini, Francesca Gorini, Sarah Monesmith, Emma Coschina, Eva Benuzzi, Daniele Fuschi, Marta Palombo, Francesca Bonomini, Fabiana Morroni, Patrizia Hrelia, Giovanni Barbara & Sabrina Angelini. (2023) New insights into irritable bowel syndrome pathophysiological mechanisms: contribution of epigenetics. Journal of Gastroenterology.
Crossref
Alireza Olyaiee, Amir Sadeghi, Abbas Yadegar, Elnaz Sadat Mirsamadi & Hamed Mirjalali. (2022) Gut Microbiota Shifting in Irritable Bowel Syndrome: The Mysterious Role of Blastocystis sp.. Frontiers in Medicine 9.
Crossref
Ying‐Xiu Dai, Ying‐Hsuan Tai, Yun‐Ting Chang, Tzeng‐Ji Chen & Mu‐Hong Chen. (2022) Bidirectional association between alopecia areata and irritable bowel syndrome: A nationwide population‐based cohort study. Australasian Journal of Dermatology 63:2.
Crossref
Sahar M. El‑Haggar, Sahar K. Hegazy, Sherief M. Abd‐Elsalam & Mostafa M Bahaa. (2021) Open‐label pilot study of ethosuximide as adjunctive therapy for relieving abdominal pain related to Irritable Bowel Syndrome. Journal of Clinical Pharmacy and Therapeutics 47:3, pages 306-312.
Crossref
Sunil Kumar, Priyanka Singh & Awanish Kumar. (2021) Targeted therapy of irritable bowel syndrome with anti-inflammatory cytokines. Clinical Journal of Gastroenterology 15:1, pages 1-10.
Crossref
Sahar M. El‑Haggar, Sahar K. Hegazy, Sherief M. Abd-Elsalam & Mostafa M. Bahaa. (2022) Pentoxifylline, a nonselective phosphodiesterase inhibitor, in adjunctive therapy in patients with irritable bowel syndrome treated with mebeverine. Biomedicine & Pharmacotherapy 145, pages 112399.
Crossref
E. Arvidsson NordströmC. TeixeiraC. MonteliusB. JeppssonN. Larsson. (2021) Lactiplantibacillus plantarum 299v (LP299V ® ): three decades of research . Beneficial Microbes 12:5, pages 441-465.
Crossref
Elizabeth J. Videlock & Lin Chang. (2021) Latest Insights on the Pathogenesis of Irritable Bowel Syndrome. Gastroenterology Clinics of North America 50:3, pages 505-522.
Crossref
Muhammad Aziz, Jaya Kumar, Khairul Muhammad Nawawi, Raja Raja Ali & Norfilza Mokhtar. (2021) Irritable Bowel Syndrome, Depression, and Neurodegeneration: A Bidirectional Communication from Gut to Brain. Nutrients 13:9, pages 3061.
Crossref
Anna-Karin Norlin, Susanna Walter, Adriane Icenhour, Åsa V. Keita, Sigrid Elsenbruch, Olga Bednarska, Michael P. Jones, Rozalyn Simon & Maria Engström. (2021) Fatigue in irritable bowel syndrome is associated with plasma levels of TNF-α and mesocorticolimbic connectivity. Brain, Behavior, and Immunity 92, pages 211-220.
Crossref
Mattia Cappelletti, Emiliana Tognon, Linda Vona, Katia Basello, Andrea Costanzi, Michela Carola Speciani & Attilio Francesco Speciani. (2020) Food-specific serum IgG and symptom reduction with a personalized, unrestricted-calorie diet of six weeks in Irritable Bowel Syndrome (IBS). Nutrition & Metabolism 17:1.
Crossref
Caterina Carco, Wayne Young, Richard B. Gearry, Nicholas J. Talley, Warren C. McNabb & Nicole C. Roy. (2020) Increasing Evidence That Irritable Bowel Syndrome and Functional Gastrointestinal Disorders Have a Microbial Pathogenesis. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Pasquale Mansueto, Diana Di Liberto, Francesca Fayer, Maurizio Soresi, Girolamo Geraci, Antonio Giulio Giannone, Aurelio Seidita, Alberto D’Alcamo, Francesco La Blasca, Marianna Lo Pizzo, Ada Maria Florena, Francesco Dieli & Antonio Carroccio. (2020) TNF-α, IL-17, and IL-22 production in the rectal mucosa of nonceliac wheat sensitivity patients: role of adaptive immunity. American Journal of Physiology-Gastrointestinal and Liver Physiology 319:3, pages G281-G288.
Crossref
Lienda Bashier El, Doa Shams, Nazik Babikr, Mohammed Madani, Sara Abdelghani & Hisham Ali Waggia. (2020) Serum Levels of Interferon Gamma INF-γ and Interleukin 10 Il-10: an Immunological Aspect among Irritable Bowel Syndrome Patients. Pakistan Journal of Biological Sciences 23:7, pages 898-903.
Crossref
Tsvetelina Velikova, Kalina Tumangelova-Yuzeir, Ralitsa Georgieva, Ekaterina Ivanova-Todorova, Elena Karaivanova, Ventsislav Nakov, Radislav Nakov & Dobroslav Kyurkchiev. (2020) Lactobacilli Supplemented with Larch Arabinogalactan and Colostrum Stimulates an Immune Response towards Peripheral NK Activation and Gut Tolerance. Nutrients 12:6, pages 1706.
Crossref
Chun-Yan Zhang, Xin Yao, Gang Sun & Yun-Sheng Yang. (2019) Close association between abnormal expressed enzymes of energy metabolism and diarrhea-predominant irritable bowel syndrome. Chinese Medical Journal 132:2, pages 135-144.
Crossref
Stephanie Balikji, Marlou Mackus, Karel Brookhuis, Johan Garssen, Aletta Kraneveld, Thomas Roth & Joris Verster. (2018) The Association of Insomnia, Perceived Immune Functioning, and Irritable Bowel Syndrome Complaints. Journal of Clinical Medicine 7:9, pages 238.
Crossref